| Literature DB >> 26833395 |
José Alvarez-Nemegyei1, Ingris Peláez-Ballestas2, Mario Goñi3, Flor Julián-Santiago4, Conrado García-García2, Rosana Quintana5, Adriana M R Silvestre6, Imelda García-Olivera7, Nora A Mathern8, Adalberto Loyola-Sanchez9, Silvana Conti6, Alvaro J Sanabria6, Bernardo A Pons-Estel5.
Abstract
This study assessed the overall and specific prevalence of the main rheumatic regional pain syndromes (RRPS) in four Latin-American indigenous groups. A Community Oriented Program for Control of Rheumatic Diseases (COPCORD) methodology-based census study was performed in 4240 adults (participation rate: 78.88 %) in four indigenous groups: Chontal (Oaxaca, Mexico, n = 124), Mixteco (Oaxaca, Mexico; n = 937), Maya-Yucateco (Yucatán, Mexico; n = 1523), and Qom (Rosario, Argentina; n = 1656). Subjects with musculoskeletal pain were identified using a cross-cultural, validated COPCORD questionnaire administered by bilingual personnel, and reviewed by general practitioners or rheumatologists using standardized case definitions for the 12 most frequent RRPS. The overall prevalence of RRPS was confirmed in 239 cases (5.64 %, 95 % CI: 4.98-6.37). The prevalence in each group was Chontal n = 19 (15.32 %, 95 % CI: 10.03-22.69); Maya-Yucateco n = 165 (10.83 %, 95 % CI: 9.37-12.49); Qom n = 48 (2.90 %, 95 % CI: 2.19-3.82); and Mixteco n = 7 (0.75 %, 95 % CI: 0.36-1.53). In the whole sample, the syndrome-specific prevalence was rotator cuff tendinopathy: 1.98 % (95 % CI: 1.60-2.45); lateral epicondylalgia: 0.83 % (95 % CI: 0.59-1.15); medial epicondylalgia: 0.73 % (95 % CI: 0.52-1.04); biceps tendinopathy: 0.71 % (95 % CI: 0.50-1.01); anserine syndrome: 0.64 % (95 % CI: 0.44-0.92); inferior heel pain: 0.61 % (95 % CI: 0.42-0.90); trochanteric syndrome: 0.49 % (95 % CI: 0.25-0.64); de Quervain's tendinopathy: 0.45 % (95 % CI: 0.29-0.70); trigger finger: 0.42 % (95 % CI: 0.27-0.67); carpal tunnel syndrome: 0.28 % (95 % CI: 0.16-0.49); Achilles tendinopathy (insertional): 0.12 % (95 % CI: 0.05-0.28); and Achilles tendinopathy (non-insertional): 0.07 % (95 % CI: 0.02-0.21). Leaving aside the comparison between Maya-Yucateco and Chontal groups (p = 0.18), we found significant differences (p < 0.001) in overall RRPS prevalence between the remaining pairs of indigenous groups. Syndrome-specific prevalences were also different between groups. Our findings support the hypothesis that overall RRPS prevalence and syndrome-specific prevalences are modulated by population-specific factors.Entities:
Keywords: Bursitis; Epidemiology; Ethnicity; Prevalence; Rheumatic regional pain syndrome; Soft tissue rheumatology; Tendonitis
Mesh:
Year: 2016 PMID: 26833395 PMCID: PMC4954835 DOI: 10.1007/s10067-016-3188-y
Source DB: PubMed Journal: Clin Rheumatol ISSN: 0770-3198 Impact factor: 2.980
Sample size, participation rate, basic demographic features, and the prevalence of musculoskeletal pain in the last 7 days between the four studied indigenous groups
| Indigenous group: | Participation | Female/male | Participant’s age (years) | MS pain in last 7 days | |||||
|---|---|---|---|---|---|---|---|---|---|
|
| % |
| % | Mean ± D.S. | Range |
| % | 95 % CI | |
| Maya-Yucateco ( | 1523 | 62.36 | 917/606 | 60.2/39.8 | 45.2 ± 17.9 | 18–104 | 592 | 38.87 | 36.45–41.34 |
| Mixteco ( | 937 | 98.52 | 570/367 | 60.8/39.2 | 46.9 ± 20.1 | 17–97 | 432 | 46.10 | 42.92–49.31 |
| Chontal ( | 124 | 96.87 | 72/52 | 58.1/41.9 | 47.0 ± 18.1 | 19–89 | 51 | 41.13 | 32.86–49.93 |
| Qom ( | 1656 | 80.62 | 1020/636 | 61.6/38.4 | 35.3 ± 13.9 | 18–105 | 471 | 28.44 | 26.32–30.66 |
| Overall ( | 4240 | 78.88 | 2579/1661 | 60.8/39.2 | 41.8 ± 17.8 | 17–105 | 1546 | 36.55 | 35.11–38.01 |
MS musculoskeletal
Comparisona of the RRPS overall prevalence between the four studied indigenous groups
| Ethnical group: | Subjects with RRPS | Prevalence (%) | 95 % CIb |
|---|---|---|---|
| Chontal ( | 19 | 15.32 | 10.03–22.69 |
| Maya-Yucateco ( | 165 | 10.83 | 9.37–12.49 |
| Qom ( | 48 | 2.90 | 2.19–3.82 |
| Mixteco ( | 7 | 0.75 | 0.36–1.53 |
a X 2 results: Chontal vs. Maya: p = 0.18; Chontal vs. Qom: p < 0.0001; Chontal vs. Mixteco: p < 0.0001; Mava vs. Qom: p < 0.0001; Maya vs. Mixteco: p < 0.0001; Qom vs. Mixteco: p < 0.0001
bPrevalence’s 95 % confidence interval
Overall and gender specific prevalencea for every one of the 12 studied RRPS in the whole surveyed population
| Syndrome: | Overall | Men | Women | |||
|---|---|---|---|---|---|---|
| Cases | Prevalence | Cases | Prevalence | Cases | Prevalence | |
| Rotator cuff tendinopathy | 84 | 1.98 (1.60–2.45) | 30 | 1.81 (1.27–2.57) | 54 | 2.09 (1.61–2.72) |
| Biceps tendinopathy | 30 | 0.71 (0.50–1.01) | 12 | 0.72 (0.41–1.26) | 18 | 0.70 (0.44–1.10) |
| Lateral epicondylalgia | 35 | 0.83 (0.59–1.15) | 18 | 1.08 (0.69–1.71) | 17 | 0.66 (0.41–1.05) |
| Medial epicondylalgia | 31 | 0.73 (0.52–1.04) | 13 | 0.78 (0.46–1.33) | 18 | 0.70 (0.44–1.10) |
| Carpal tunnel syndrome | 12 | 0.28 (0.16–0.49) | 2 | 0.12 (0.03–0.44) | 10 | 0.39 (0.21–0.71) |
| de Quervain’s tendinopathy | 19 | 0.45 (0.29–0.70) | 3 | 0.18 (0.06–0.53) | 16 | 0.62 (0.38–1.01) |
| Trigger finger | 18 | 0.42 (0.27–0.67) | 4 | 0.24 (0.09–0.62) | 14 | 0.54 (0.32–0.91) |
| Trochanteric syndrome | 17 | 0.49 (0.25–0.64) | 4 | 0.24 (0.09–0.629 | 13 | 0.50 (0.29–0.86) |
| Anserine syndrome | 27 | 0.64 (0.44–0.92 | 9 | 0.54 (0.29–1.03) | 18 | 0.70 (0.44–1.10) |
| Achilles tendinopathy (non-insertional) | 3 | 0.07 (0.02–0.21) | 0 | – | 3 | 0.12 (0.04–0.34) |
| Achilles tendinopathy (insertional) | 5 | 0.12 (0.05–0.28) | 1 | 0.06 (0.01–0.34) | 4 | 0.16 (0.06–0.40) |
| Inferior heel pain | 26 | 0.61 (0.42–0.90) | 8 | 0.48 (0.24–0.95) | 18 | 0.70 (0.44–1.10) |
a95 % confidence interval between brackets
Comparative prevalencea of the 12 assessed RRPS between the four studied indigenous groups
| Syndrome: | Ethnical group | |||||||
|---|---|---|---|---|---|---|---|---|
| Qom | Mixteco | Chontal | Maya-Yucateco | |||||
| Cases | Prevalence | Cases | Prevalence | Cases | Prevalence | Cases | Prevalence | |
| Rotator cuff tendinopathy | 15 | 0.91 (0.55–1.49) | 4 | 0.43 (0.17–1.09) | 10 | 8.06 (4.44–14.21) | 55 | 3.61 (2.78–4.67) |
| Biceps tendinopathy | 11 | 0.66 (0.37–1.19) | 1 | 0.11 (0.02–0.60) | 4 | 3.23 (1.26–8.00) | 14 | 0.92 (0.55–1.54) |
| Lateral epicondylalgia | 9 | 0.54 (0.29–1.03) | 0 | – | 1 | 0.81 (0.14–4.43) | 25 | 1.64 (1.11–2.41) |
| Medial epicondylalgia | 2 | 0.12 (0.03–0.44) | 1 | 0.11 (0.02–0.60) | 3 | 2.42 (0.83–6.87) | 25 | 1.64 (1.11–2.41) |
| Carpal tunnel syndrome | 3 | 0.18 (0.06–0.53) | 0 | – | 4 | 3.23 (1.26–8.00) | 5 | 0.33 (0.14–0.77) |
| de Quervain’s tendinopathy | 2 | 0.12 (0.03–0.44) | 0 | – | 4 | 3.23 (1.26–8.00) | 13 | 0.85 (0.50–1.45) |
| Trigger finger | 2 | 0.12 (0.03–0.44) | 0 | – | 0 | – | 16 | 1.05 (0.65–1.70) |
| Trochanteric syndrome | 4 | 0.24 (0.09–0.62) | 0 | – | 2 | 1.61 (0.44–5.69) | 11 | 0.72 (0.40–1.29) |
| Anserine syndrome | 2 | 0.12 (0.03–0.44) | 0 | – | 5 | 4.03 (1.73–9.09) | 20 | 1.31 (0.85–2.02) |
| Achilles tendinopathy (non-insertional) | 0 | – | 0 | – | 1 | 0.81 (0.14–4.43) | 2 | 0.13 (0.04–0.48) |
| Achilles tendinopathy (insertional) | 0 | – | 0 | – | 5 | 4.03 (1.73–9.09) | 0 | – |
| Inferior heel pain | 4 | 0.24 (0.09–0.62) | 1 | 0.11 (0.02–0.60) | 7 | 5.65 (2.76–11.19) | 14 | 0.92 (0.55–1.54) |
a95 % confidence interval between brackets